Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study
- PMID: 19962808
- PMCID: PMC2866514
- DOI: 10.1053/j.ajkd.2009.09.014
Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study
Abstract
Background: A low rate of blood pressure control has been reported in patients with chronic kidney disease (CKD). These data were derived from population-based samples with a low rate of CKD awareness.
Study design: Cross-sectional.
Setting & participants: Data from the baseline visit of the Chronic Renal Insufficiency Cohort (CRIC) Study (n = 3,612) were analyzed. Participants with an estimated glomerular filtration rate of 20-70 mL/min/1.73 m(2) were identified from physician offices and review of laboratory databases.
Outcomes: Prevalence and awareness of hypertension, treatment patterns, control rates, and factors associated with hypertension control.
Measurements: Following a standardized protocol, blood pressure was measured 3 times by trained staff, and hypertension was defined as systolic blood pressure > or =140 mm Hg and/or diastolic blood pressure > or =90 mm Hg and/or self-reported antihypertensive medication use. Patients' awareness and treatment of hypertension were defined using self-report, and 2 levels of hypertension control were evaluated: systolic/diastolic blood pressure <140/90 and <130/80 mm Hg.
Results: The prevalence of hypertension was 85.7%, and 98.9% of CRIC participants were aware of this diagnosis and 98.3% were treated with medications, whereas 67.1% and 46.1% had hypertension controlled to <140/90 and <130/80 mm Hg, respectively. Of CRIC participants with hypertension, 15%, 25%, 26%, and 32% were using 1, 2, 3, and > or =4 antihypertensive medications, respectively. After multivariable adjustment, older patients, blacks, and those with higher urinary albumin excretion were less likely, whereas participants using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were more likely to have controlled their hypertension to <140/90 and <130/80 mm Hg.
Limitations: Data were derived from a single study visit.
Conclusions: Despite almost universal hypertension awareness and treatment in this cohort of patients with CKD, rates of hypertension control were suboptimal.
Copyright 2010 National Kidney Foundation, Inc. All rights reserved.
Figures



Comment in
-
Blood pressure control in CKD patients: why do we fail to implement the guidelines?Am J Kidney Dis. 2010 Mar;55(3):415-8. doi: 10.1053/j.ajkd.2009.12.013. Am J Kidney Dis. 2010. PMID: 20189048 No abstract available.
Similar articles
-
CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies.Am J Kidney Dis. 2011 Aug;58(2):214-27. doi: 10.1053/j.ajkd.2011.05.010. Epub 2011 Jun 25. Am J Kidney Dis. 2011. PMID: 21705121 Free PMC article.
-
Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.Am J Kidney Dis. 2010 Sep;56(3):447-57. doi: 10.1053/j.ajkd.2010.02.348. Epub 2010 May 14. Am J Kidney Dis. 2010. PMID: 20471734 Free PMC article.
-
Hypertension Control in Adults With CKD in China: Baseline Results From the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).Am J Hypertens. 2018 Mar 10;31(4):486-494. doi: 10.1093/ajh/hpx222. Am J Hypertens. 2018. PMID: 29304216
-
Isolated Diastolic Hypertension and Kidney and Cardiovascular Outcomes in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.Kidney Med. 2023 Sep 22;5(12):100728. doi: 10.1016/j.xkme.2023.100728. eCollection 2023 Dec. Kidney Med. 2023. PMID: 38046908 Free PMC article.
-
Blood Pressure, Incident Cognitive Impairment, and Severity of CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.Am J Kidney Dis. 2023 Oct;82(4):443-453.e1. doi: 10.1053/j.ajkd.2023.03.012. Epub 2023 May 27. Am J Kidney Dis. 2023. PMID: 37245689 Free PMC article.
Cited by
-
Disentangling the multiple links between renal dysfunction and cerebrovascular disease.J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):88-97. doi: 10.1136/jnnp-2019-320526. Epub 2019 Sep 11. J Neurol Neurosurg Psychiatry. 2020. PMID: 31511306 Free PMC article. Review.
-
Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients.PLoS One. 2013 Dec 31;8(12):e84848. doi: 10.1371/journal.pone.0084848. eCollection 2013. PLoS One. 2013. PMID: 24391978 Free PMC article. Clinical Trial.
-
Arterial Stiffness in CKD: A Review.Am J Kidney Dis. 2019 Feb;73(2):240-247. doi: 10.1053/j.ajkd.2018.04.005. Epub 2018 Jun 19. Am J Kidney Dis. 2019. PMID: 29908694 Free PMC article. Review.
-
Antihypertensive Treatment Patterns in CKD Stages 3 and 4: The CKD-REIN Cohort Study.Kidney Med. 2024 Oct 9;6(12):100912. doi: 10.1016/j.xkme.2024.100912. eCollection 2024 Dec. Kidney Med. 2024. PMID: 39574792 Free PMC article.
-
Sex differences in the association of dietary inflammatory index with chronic kidney disease in US adults.Sci Rep. 2024 Dec 4;14(1):30235. doi: 10.1038/s41598-024-78307-4. Sci Rep. 2024. PMID: 39632932 Free PMC article.
References
-
- Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047. - PubMed
-
- Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844–850. - PubMed
-
- Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med. 2001;161:1207–1216. - PubMed
-
- Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med. 2006;166:1884–1891. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 DK061028/DK/NIDDK NIH HHS/United States
- 5U01DK60980/DK/NIDDK NIH HHS/United States
- 5U01DK060902/DK/NIDDK NIH HHS/United States
- 5U01DK060984/DK/NIDDK NIH HHS/United States
- 5U01DK-06102/DK/NIDDK NIH HHS/United States
- U01 DK060902/DK/NIDDK NIH HHS/United States
- U01 DK060990/DK/NIDDK NIH HHS/United States
- K01 DK064860/DK/NIDDK NIH HHS/United States
- T32 DK060455/DK/NIDDK NIH HHS/United States
- 5U01DK060963/DK/NIDDK NIH HHS/United States
- U01 DK060984/DK/NIDDK NIH HHS/United States
- U01 DK061021/DK/NIDDK NIH HHS/United States
- U01 DK060980/DK/NIDDK NIH HHS/United States
- 5U01DK060990/DK/NIDDK NIH HHS/United States
- T32 DK007785/DK/NIDDK NIH HHS/United States
- U01 DK060963/DK/NIDDK NIH HHS/United States
- 5U01DK061028/DK/NIDDK NIH HHS/United States
- 5U01DK061021/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases